Search
News
Important Only
Other
BXP Upsizes Unsecured Credit Facility To $2.95 Billion & Commercial Paper Program To $750 Million
March 31 (Reuters) - BXP Inc BXP.N:BXP UPSIZES UNSECURED CREDIT FACILITY TO $2.95 BILLION & COMMERCIAL PAPER PROGRAM TO $750 MILLIONBXP INC - REVOLVING CREDIT FACILITY MATURITY DATE EXTENDED TO MARCH 2030Reuters
Mar 31, 2025
Other
Luca Mining Announces Commercial Production At Tahuehueto And Provides 2025 Production Guidance
March 31 (Reuters) - Luca Mining Corp LUCA.V:LUCA MINING ANNOUNCES COMMERCIAL PRODUCTION AT TAHUEHUETO AND PROVIDES 2025 PRODUCTION GUIDANCELUCA MINING- EXPECTS PRODUCING 85,000-100,000 GOLD EQUIVALENT OUNCES IN 2025Reuters
Mar 31, 2025
Other
Vaxcyte Announces Positive Topline Results From VAX-24 Infant Phase 2 Dose-Finding Study
March 31 (Reuters) - Vaxcyte Inc PCVX.O:VAXCYTE ANNOUNCES POSITIVE TOPLINE RESULTS FROM VAX-24 INFANT PHASE 2 DOSE-FINDING STUDYVAXCYTE INC - VAX-24 WELL-TOLERATED WITH SAFETY PROFILE SIMILAR TO PCV20VAXCYTE INC: VAX-31 PHASE 2 DOSE-FINDING STUDY TOPLINE DATA IS EXPECTED IN MID-2026VAXCYTE INC: VAX-...Reuters
Mar 31, 2025
Other
Baker Hughes Co - Lynn L. Elsenhans To Not Stand For Re-Election At 2025 Annual Meeting - SEC Filing
March 31 (Reuters) - Baker Hughes Co BKR.O:BAKER HUGHES CO - LYNN L. ELSENHANS TO NOT STAND FOR RE-ELECTION AT 2025 ANNUAL MEETING - SEC FILINGSource text: [ID:n0001193125-25-067691]Reuters
Mar 31, 2025
Other
Phaos Technology (Cayman) Holdings Ltd Says In The IPO, Selling Shareholders Offering Additional 900,090 Class A Ordinary Shares - SEC Filing
March 31 (Reuters) - PHAOS TECHNOLOGY (CAYMAN) HOLDINGS LTD SAYS IN THE IPO, SELLING SHAREHOLDERS OFFERING ADDITIONAL 900,090 CLASS A ORDINARY SHARES - SEC FILINGSource text: [ID:n0001641172-25-001406]Reuters
Mar 31, 2025
Other
LPL Financial Holdings Inc Files For Common Stock Offering Of Up To $1.5 Billion - SEC Filing
March 31 (Reuters) - LPL Financial Holdings Inc LPLA.O:LPL FINANCIAL HOLDINGS INC FILES FOR COMMON STOCK OFFERING OF UP TO $1.5 BILLION - SEC FILINGSource text: [ID:n0001193125-25-067673]Reuters
Mar 31, 2025
Other
Avery Dennison Corp - Gregory S. Lovins To Resume As CFO Effective April 1 - SEC Filing
March 31 (Reuters) - Avery Dennison Corp AVY.N:AVERY DENNISON CORP - GREGORY S. LOVINS TO RESUME AS CFO EFFECTIVE APRIL 1 - SEC FILINGAVERY DENNISON CORP - DANNY G. ALLOUCHE TO CEASE SERVING AS INTERIM CFO ON MARCH 31, 2025- SEC FILINGSource text: [ID:n0000008818-25-000007]Reuters
Mar 31, 2025
Other
Sempra Announces Continuation Of Capital Recycling Program
March 31 (Reuters) - Sempra SRE.N:SEMPRA ANNOUNCES CONTINUATION OF CAPITAL RECYCLING PROGRAMSEMPRA - TO SELL ENERGY INFRASTRUCTURE ASSETS IN MEXICOSEMPRA - SELLING MINORITY INTEREST IN SEMPRA INFRASTRUCTURESEMPRA - TO SELL MINORITY INTEREST IN SEMPRRA INFRASTRUCTURESEMPRA - EXPECTS TO DIVEST NON-COR...Reuters
Mar 31, 2025
Other
Gyre Therapeutics Announces NMPA Approval For Clinical Trial Evaluating Pirfenidone Capsules In Oncology-Related Pulmonary Complications
March 31 (Reuters) - Gyre Therapeutics Inc GYRE.O:GYRE THERAPEUTICS ANNOUNCES NMPA APPROVAL FOR CLINICAL TRIAL EVALUATING PIRFENIDONE CAPSULES IN ONCOLOGY-RELATED PULMONARY COMPLICATIONSReuters
Mar 31, 2025
Cryptocurrencies
New Crypto BTC Bull Token Heats Up as Saylor’s Moves Pressure S&P 500 to Buy More Bitcoin
Elliot Chun, a partner at the tech-focused financial advisory firm Architect Partners, forecasts that by 2030, one in four S&P 500 companies will have Bitcoin on their balance sheets. Radical prediction? Only two S&P companies currently own Bitcoin – Tesla and Block. But with more and more c...Bitcoinist
Mar 31, 2025
Stocks
Biotech stocks tumble on reports FDA's top vaccine regulator to leave
March 31 (Reuters) - Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned, fanning worries over slower reviews for breakthrough treatments. Peter Marks, who played a key role in U....Reuters
Mar 31, 2025
Other
Quantum Biopharma Announces Closing Of Final $2.42 Million Tranche Of $5 Million Total Financing On Improved Terms
March 31 (Reuters) - Quantum BioPharma Ltd QNTM.CD:QUANTUM BIOPHARMA ANNOUNCES CLOSING OF FINAL $2.42 MILLION TRANCHE OF $5 MILLION TOTAL FINANCING ON IMPROVED TERMSReuters
Mar 31, 2025
Other
Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer
March 31 (Reuters) - Kairos Pharma Ltd KAPA.A:KAIROS PHARMA LTD. ANNOUNCES COMPLETED ENROLLMENT OF THE SAFETY ARM OF ITS PHASE 2 CLINICAL TRIAL OF ENV105 IN METASTATIC, CASTRATION-RESISTANT PROSTATE CANCERKAIROS PHARMA LTD - SAFETY AND EFFICACY DATA READOUT EXPECTED IN FIRST HALF OF 2025Reuters
Mar 31, 2025
Stocks
HEDGE FLOW-Hedge funds flee techs stocks before tariffs take hold, says Goldman Sachs
By Nell Mackenzie LONDON, March 31 (Reuters) - Hedge funds last week ditched tech stocks at the fastest pace in six months and at the highest levels in five years, according to Goldman Sachs GS.N, as world markets tumbled on worries over U.S. President Donald Trump's April 2 tariff deadline.I...Reuters
Mar 31, 2025
Featured Tools
Top News
TSLA Q1 Earnings Preview: Tesla Snaps 8-Week Slump—Now Buy the Dip or Wait?
Why AMD Stock Popped: 12-Day Winning Rally Signals CPU Renaissance in Agentic AI Push
APLD Stock Surge: How CoreWeave Lease Amendments and Delta Forge 1 Milestones De-risk the Bull Case
AI Chip Startup Cerebras Refiles for IPO, Testing Nvidia’s Pricing Power
GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?
Market Movers
Tradingkey
